美國Cell Therapeutics www.celltherapeutics.com 
Cell Therapeutic公司的arsenic trioxide(三氧化二砷)
美國FDA已批準Cell Therapeutic公司的癌癥治療劑三氧化二砷用于治療脊髓發(fā)育不良癥狀(MDS)的罕見藥品的指定。MDS也稱為前期的白血病或“不完全燃燒”的白血病，MDS是骨髓不能正常起作用以及產(chǎn)生的血細胞不足。該公司最近為三氧化二砷治療另一種罕見病復(fù)發(fā)的或難治的急性早幼粒細胞白血病申報了美國的新藥申請書，它對這種適應(yīng)癥具有最快的跟蹤狀態(tài)，這種產(chǎn)品對治療多發(fā)性骨髓瘤具有罕見的藥品狀態(tài)

Cell Therapeutics, Inc., is a biopharmaceutical company focused on developing and commercializing novel agents that improve the safety and efficacy of existing standard-of-care chemotherapies, and those with unique,new mechanisms to kill cancer cells. We use genomic
information to determine which tumors have the greatest chance of responding favorably to a specific drug candidate.
This has the potential to change the way anticancer drugs are developed, by allowing investigators to pick the right drug for the right patient.